Physician

Alireza Katouzian, MD

According to 2025 Medicare claims, Alireza Katouzian, MD (NPI: 1285665224) practices pain management in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is ALIREZA KATOUZIAN, MD INC. (NPI: 1386675049; TIN: 770405947) and primary practice location at 93010-2521. Katouzian is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Katouzian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 1,430 HCPCS/CPT codes, and received $133,717 in Medicare payments. The top billing code was 64635 (Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint). Part D data shows 1,187 prescription claims across 172 beneficiaries totaling $51,867 in drug costs, led by Diclofenac Potassium (Diclofenac Potassium). Open Payments data shows 112 records totaling $5,352. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $40,995 and ending at $51,867. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	493	1,647	$141,288
2016	485	1,434	$149,344
2017	440	1,357	$143,959
2018	471	1,389	$140,741
2019	550	1,630	$157,447
2020	512	1,838	$167,678
2021	631	2,256	$214,117
2022	526	1,778	$171,895
2023	435	1,515	$146,890
2024	438	1,430	$133,717

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	79	527	$40,995
2016	83	564	$26,969
2017	97	831	$38,446
2018	123	860	$36,050
2019	105	531	$25,208
2020	103	564	$23,567
2021	111	582	$24,771
2022	148	1,129	$37,660
2023	151	1,297	$50,735
2024	172	1,187	$51,867

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64635	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint	44	44	$215
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	487	$92
01938	Anesthesia for injection, drainage or aspiration procedures on spine or spinal cord of lower back accessed through skin using imaging guidance	121	143	$89
62323	Injection of substance into lower spine canal using imaging guidance	72	85	$70
64636	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint	42	42	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Diclofenac Potassium	Diclofenac Potassium	13	390	$9,943
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	187	4,473	$4,963
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	187	5,190	$3,907
Buprenorphine	Buprenorphine	12	338	$3,147
Pregabalin	Pregabalin	71	2,278	$1,525

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$5,352	BIOTRONIK NRO, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alireza Katouzian, MD?

Tedicare shows public-source Medicare data for Alireza Katouzian, MD (NPI 1285665224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alireza Katouzian, MD have ACO affiliation data?

Alireza Katouzian, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Alireza Katouzian, MD?

Alireza Katouzian, MD is linked to ALIREZA KATOUZIAN, MD INC. (billing NPI 1386675049) in the available physician profile data.

Does Alireza Katouzian, MD have Open Payments data?

Alireza Katouzian, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.